These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25546244)

  • 1. Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study.
    Sant'anna RT; Leiria TL; Nascimento T; Sant'anna JR; Kalil RA; Lima GG; Verma A; Healey JS; Birnie DH; Essebag V
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):417-23. PubMed ID: 25546244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
    Du L; Zhang Y; Wang W; Hou Y
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices.
    Ghanbari H; Phard WS; Al-Ameri H; Latchamsetty R; Jongnarngsin K; Crawford T; Good E; Chugh A; Oral H; Bogun F; Morady F; Pelosi F
    Am J Cardiol; 2012 Nov; 110(10):1482-8. PubMed ID: 22906894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysis.
    Yang X; Wang Z; Zhang Y; Yin X; Hou Y
    Europace; 2015 Jul; 17(7):1076-84. PubMed ID: 25713013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
    Siegal D; Yudin J; Kaatz S; Douketis JD; Lim W; Spyropoulos AC
    Circulation; 2012 Sep; 126(13):1630-9. PubMed ID: 22912386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.
    Essebag V; Healey JS; Ayala-Paredes F; Kalfon E; Coutu B; Nery P; Verma A; Sapp J; Philippon F; Sandhu RK; Coyle D; Eikelboom J; Wells G; Birnie DH
    Am Heart J; 2016 Mar; 173():102-7. PubMed ID: 26920602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
    Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
    Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
    Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
    Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
    J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early postoperative bridging anticoagulation after mechanical heart valve replacement: a systematic review and meta-analysis.
    Passaglia LG; de Barros GM; de Sousa MR
    J Thromb Haemost; 2015 Sep; 13(9):1557-67. PubMed ID: 26178802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy.
    Pecha S; Ayikli A; Wilke I; Hakmi S; Yildirim Y; Gosau N; Reichenspurner H; Willems S; Aydin MA
    Heart Vessels; 2018 Apr; 33(4):441-446. PubMed ID: 29030709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulation continuation compared with heparin bridging therapy among high risk patients undergoing implantation of cardiac rhythm devices: a meta-analysis.
    Feng L; Li Y; Li J; Yu B
    Thromb Haemost; 2012 Dec; 108(6):1124-31. PubMed ID: 23051884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.
    He H; Ke BB; Li Y; Han FS; Li X; Zeng YJ
    J Interv Card Electrophysiol; 2017 Oct; 50(1):65-83. PubMed ID: 28842832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
    Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
    Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pacemaker or defibrillator surgery without interruption of anticoagulation.
    Birnie DH; Healey JS; Wells GA; Verma A; Tang AS; Krahn AD; Simpson CS; Ayala-Paredes F; Coutu B; Leiria TL; Essebag V;
    N Engl J Med; 2013 May; 368(22):2084-93. PubMed ID: 23659733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
    Hammerstingl C; Omran H
    Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
    Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
    Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
    Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
    Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
    Spyropoulos AC; Al-Badri A; Sherwood MW; Douketis JD
    J Thromb Haemost; 2016 May; 14(5):875-85. PubMed ID: 26988871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Perioperative Anticoagulation for Device Implantation.
    Stewart MH; Morin DP
    Card Electrophysiol Clin; 2018 Mar; 10(1):99-109. PubMed ID: 29428146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.